Eisai Wins Dismissal Of Apotex's Suit Over Aricept
A federal judge has nixed Apotex Corp.'s declaratory judgment suit against Eisai Inc. over four patents for Alzheimer's disease drug Aricept, thwarting the plaintiff's attempt to begin selling a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article